Arvinas, Inc. Announces First-Ever FDA Approval for PROTAC Drug and Reports Q1 2026 Financial Results
Arvinas, Inc. Q1 2026 Financial Results & Corporate Update ...
Sign in to continue:
Arvinas, Inc. Q1 2026 Financial Results & Corporate Update ...
Ampco-Pittsburgh Corporation Q1 2026 Financial Results: Key ...
Ralliant Corp Q1 2026 Earnings – Detailed Investor Update ...
Achieve Life Sciences Reports Q1 2026 Results and Major Busi...
Fraser and Neave, Limited Announces Major Investment in Comv...
Zebra Technologies Q1 2026 Earnings Report: Key Highlights f...
Implications for Shareholders and Potential Share Price Impa...
Vireo Growth Inc. Announces Q1 2026 Results: Major Acquisiti...
Harvard Bioscience Q1 2026 Earnings Report - Investor Summar...
NTT DC REIT FY25/26 Financial Results: Robust Growth and Str...